BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 3130106)

  • 1. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY; Davidson RG
    Prog Clin Biol Res; 1982; 95():415-41. PubMed ID: 6812079
    [No Abstract]   [Full Text] [Related]  

  • 3. Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts.
    Choy FY; Davidson RG
    Pediatr Res; 1978 Dec; 12(12):1115-20. PubMed ID: 106357
    [No Abstract]   [Full Text] [Related]  

  • 4. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
    Shafit-Zagardo B; Devine EA; Desnick RJ
    Biochim Biophys Acta; 1980 Aug; 614(2):459-65. PubMed ID: 6773581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.
    Aerts JM; Donker-Koopman WE; van Laar C; Brul S; Murray GJ; Wenger DA; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1987 Mar; 163(3):583-9. PubMed ID: 3830174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB; Glew RH; Radin NS; Vunnam RR
    Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA; Osiecki-Newman K; Dinur T; Fabbro D; Legler G; Gatt S; Desnick RJ
    J Biol Chem; 1986 Jun; 261(18):8263-9. PubMed ID: 3087971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
    Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
    van Weely S; Brandsma M; Strijland A; Tager JM; Aerts JM
    Biochim Biophys Acta; 1993 Mar; 1181(1):55-62. PubMed ID: 8457606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
    Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
    Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

  • 18. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
    Daniels LB; Glew RH; Diven WF; Lee RE; Radin NS
    Clin Chim Acta; 1981 Sep; 115(3):369-75. PubMed ID: 6794954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
    Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
    FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients.
    Sa Miranda MC; Aerts JM; Pinto R; Fontes A; de Lacerda LW; van Weely S; Barranger J; Tager JM
    Clin Genet; 1990 Sep; 38(3):218-27. PubMed ID: 2225530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.